Filing Details
- Accession Number:
- 0001209191-14-060584
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-01 17:11:48
- Reporting Period:
- 2014-09-30
- Filing Date:
- 2014-10-01
- Accepted Time:
- 2014-10-01 17:11:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1197032 | F Ian Smith | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-09-30 | 2,267 | $33.28 | 47,537 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-09-30 | 13,594 | $39.05 | 61,131 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-09-30 | 11,329 | $33.82 | 72,460 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-09-30 | 16,993 | $38.80 | 89,453 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-09-30 | 11,330 | $51.75 | 100,783 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-09-30 | 16,993 | $37.86 | 117,776 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-09-30 | 18,126 | $48.74 | 135,902 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-09-30 | 16,992 | $45.11 | 152,894 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-09-30 | 14,007 | $111.31 | 138,887 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-09-30 | 43,112 | $112.21 | 95,775 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-09-30 | 28,751 | $113.10 | 67,024 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-09-30 | 22,156 | $113.90 | 44,868 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-09-30 | 2,267 | $0.00 | 2,267 | $33.28 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-09-30 | 13,594 | $0.00 | 13,594 | $39.05 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-09-30 | 11,329 | $0.00 | 11,329 | $33.82 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-09-30 | 16,993 | $0.00 | 16,993 | $38.80 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-09-30 | 11,330 | $0.00 | 11,330 | $51.75 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-09-30 | 16,993 | $0.00 | 16,993 | $37.86 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-09-30 | 18,126 | $0.00 | 18,126 | $48.74 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-09-30 | 16,992 | $0.00 | 16,992 | $45.11 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-07-15 | No | 4 | M | Direct | |
| 0 | 2020-02-03 | No | 4 | M | Direct | |
| 0 | 2020-07-13 | No | 4 | M | Direct | |
| 10,195 | 2021-02-02 | No | 4 | M | Direct | |
| 9,062 | 2021-07-12 | No | 4 | M | Direct | |
| 23,789 | 2022-02-01 | No | 4 | M | Direct | |
| 18,124 | 2022-07-24 | No | 4 | M | Direct | |
| 37,383 | 2023-02-04 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,306 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $111.31 (range $110.61 to $111.60).
- Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $112.21 (range $111.61 to $112.60).
- Open market sales reported on this line occurred at a weighted average price of $113.10 (range $112.61 to $113.59).
- Open market sales reported on this line occurred at a weighted average price of $113.90 (range $113.61 to $114.34).
- The option vests in 16 quarterly installments from 07/16/2009.
- The option vests in 16 quarterly installments from 02/04/2010.
- The option vests in 16 quarterly installments from 07/14/2010.
- The option vests in 16 quarterly installments from 02/03/2011.
- The option vests in 16 quarterly installments from 07/13/2011.
- The option vests in 16 quarterly installments from 02/02/2012.
- The option vests in 16 quarterly installments from 07/25/2012.
- The option vests in 16 quarterly installments from 02/05/2013.
Billionaire Hedge Funds
